Username Password
S&P 500: 1,317.45 Change: +0.03%

CLAYMORE ETF TRUST 2 (CRO)

Overview
Price 0.05
Price Change Today 0.00 (0.00%)
P&P rating Rating: 0
Open Price $0.00
Previous Close $0.05
Daily Range $0.05 - $0.06
52-Week Range $0.04 - $0.14
Volume 67
chart
Other Resources for CRO
zacks.com
Commentary
No Commentary Found for This Ticker.
NetSuite, Inc. is the leading provider of on-demand, integrated business management software for growing and midsize businesses. With thousands of customers globally using NetSuite's online products and professional services, companies are enabled to manage all key business operations in a single hosted system, including: customer relationship management; order fulfillment; inventory; accounting and finance, product assembly; ecommerce; Web site management; and employee productivity.
 
Brokerage Analyst Recommendations
19 Brokerage Firms Covering N
 
   
Strong Buy
4
Buy
0
Hold
13
Sell
0
Strong Sell
2
Average Broker Recommendation (ABR): 2.75
 
N Ratings:BUY  SELL  HOLD
Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

0 Buy
0 Sell
 
Top Buy Analysis
No Buy Analysis. Be the First.

Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 05/16/12 Duke Realty Leases to Novella - Analyst Blog 0
Zacks_Analysts
0.00 03/23/12 Merge Partners AG Mednet - Analyst Blog 0
Zacks_Analysts
0.00 02/24/12 VirtualScopics Reaches the Black in 4Q - Analyst Blog 0
Zacks_Analysts
0.00 01/30/12 VirtualScopics, PPD Expand Ties - Analyst Blog 0
Zacks_Analysts
0.00 12/02/11 PPDI Shareholders Nod to Merger - Analyst Blog 0
Zacks_Analysts
0.00 11/16/11 VirtualScopics Beats by a Whisker - Analyst Blog 0
Zacks_Analysts
0.00 10/07/11 PPDI to Go Private - Analyst Blog 0
Zacks_Analysts
0.00 09/23/11 PPDI Hires New CEO - Analyst Blog 0
Zacks_Analysts
0.00 09/13/11 FDA lifts hold on RXi breast cancer vaccine trial - Analyst Blog 0
Zacks_Analysts
0.00 08/11/11 VirtualScopics EPS Meets, Sales Up - Analyst Blog 0
Pages: [ 1 ]  2   3  >>
Commentary
There are no open picks with this stock at the moment.
Picks
There are no open picks with this stock at the moment.
Sponsored Links